ABSOLVE

· Lynch Biologics LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABSOLVE, covering 2017-01-31 to 2017-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of ABSOLVE in Diabetic Foot Ulcers [Phase 2]